Hot topics close

Eli Lilly commits $5.3B to more Zepbound, Mounjaro production

Eli Lilly commits 53B to more Zepbound Mounjaro production
Boosting production and creating jobs, Eli Lilly invests $5.3 billion in Indiana plants for Zepbound and Mounjaro, with potential label expansion for Zepbound.

Two Eli Lilly manufacturing plants in Indiana are getting a $5.3 billion boost to increase production of Zepbound and Mounjaro, the company said May 24. 

The investment "represents the single largest investment in synthetic medicine [active pharmaceutical ingredient] manufacturing in U.S. history," Eli Lilly's chair and CEO David Ricks said in a news release. 

Leaders of the manufacturing sites in Lebanon, Ind., will hire 200 full-time workers to help increase production. Mounjaro is approved for Type 2 diabetes and Zepbound is indicated for chronic weight management. Eli Lilly is also eyeing a Zepbound label expansion after finding positive results in a sleep apnea trial. 

The announcement raises the company's total investment in the Lebanon site from $3.7 billion to $9 billion. 

Similar shots
News Archive
  • Bob Marley
    Bob Marley
    Traffic changes to be implemented near Carib Theatre for Bob ...
    21 Jan 2024
    11
  • Michael Kopech
    Michael Kopech
    Dodgers acquire infielder Tommy Edman and pitcher Michael ...
    22 days ago
    2
  • Probe
    Probe
    EU launches disinformation probe against social media giant Meta
    30 Apr 2024
    2
  • Niall Horan
    Niall Horan
    The Voice record: Niall Horan joins Blake Shelton, Kelly Clarkson
    20 Dec 2023
    13
This week's most popular shots